Pers Enterprises Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 25-07-2024
- Paid Up Capital ₹ 2.01 Cr
as on 25-07-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.46 Cr
as on 25-07-2024
- Satisfied Charges ₹ 29.77 Cr
as on 25-07-2024
- Revenue -6.79%
(FY 2023)
- Profit -16.08%
(FY 2023)
- Ebitda -15.30%
(FY 2023)
- Net Worth 22.58%
(FY 2023)
- Total Assets 21.32%
(FY 2023)
About Pers Enterprises
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.01 Cr.
The company currently has active open charges totaling ₹8.46 Cr. The company has closed loans amounting to ₹29.77 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sivasamy Raju and Mythili serve as directors at the Company.
- CIN/LLPIN
U74900TN2010PTC078012
- Company No.
078012
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pers Enterprises?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivasamy Raju  | Additional Director | Current | |
| Mythili | Director | 10-Nov-2010 | Current |
Financial Performance and Corporate Structure Insights of Pers Enterprises.
Pers Enterprises Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.79% decrease. The company also saw a substantial fall in profitability, with a 16.08% decrease in profit. The company's net worth Soared by an impressive increase of 22.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pers Enterprises?
In 2023, Pers Enterprises had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Srm Institutes For Medical Science Private Limited
Active
7 months 27 days Sivasamy Raju is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Oct 2021 | ₹3.50 Cr | Open |
Yes Bank Limited Creation Date: 05 Jan 2019 | ₹4.96 Cr | Open |
Yes Bank Limited Creation Date: 29 Jun 2017 | ₹7.35 Cr | Satisfied |
How Many Employees Work at Pers Enterprises?
Pers Enterprises has a workforce of 183 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Aug 28, 2015, Pers Enterprises has raised a total of ₹ 2 Cr, with the most recent deal valued at ₹ 2 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
